blinatumomab,nelarabine,rituximab
novartis,roche,astellas,amgen
['dlbcl', 'leusm', 'blinatumomab', 'elara', 'nelarabine', 'novo ']
congress #ash22 | , delivers results from the graall-2014 trial in adult pts with ph-all which revealed that age-adapted chemotherapy intensity and mrd-driven indication for hsct significantly reduced trm, improved os, and well-tolerated overall #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm